The Efficacy and Adverse Effects of Haloperidol and Olanzapine: a Randomized Controlled Study.

WANG Yan,CAI Liwei,ZHANG Hongxing,Du Bo,JIN Chao,YAN Hao,LI Lingzhi,LIU Qi,YAN Jun,MA Wenbin,LI Keqing,LV Luxian,ZHANG Hongyan,YUE Weihua,ZHANG Dai,WANG Lifang

DOI: https://doi.org/10.3969/j.issn.1002-0152.2012.04.005

2012-01-01

Abstract:Objective To compare the efficacy and adverse effects of haloperidol and olanzapine in treatment of patients with schizophrenia.Methods A randomized,multi-center,controlled clinical trial was conducted.Patients with schizophrenia were randomly assigned into haloperidol(n = 120) and olanzapine(n = 252) groups to receive monotherapy with either drug alone for 6 weeks.The positive and negative syndrome scale(PANSS),body mass index(BMI),rating scale for extrapyramdal side effects(RSESE),barnes akathisia rating scale(BARS) and abnormal involuntary movement scale(AIMS) were assessed at baseline,2,4,and 6 weeks following treatment.Moreover,a series of parameters including blood glucose,lipid metabolism and hepatic functions were detected at same time points.Results There were no significant difference in PANSS scores between two groups at baseline.At the end of 6 weeks,the PANSS score of were lower in haloperidol group than in olanzaping group(53.31 ± 1.64 vs.58.05 ± 1.02) whereas the reduction rates of PANSS in were higher in haloperidol group than in olanzapine group(60.63 ± 2.86% vs.52.45 ± 1.80%),P 0.05.The difference at effective rates was no statistically significant between these two groups(66.7% vs.62.7%).The BMI changes(0.08 ± 0.20 kg/m2 vs.0.91 ± 0.12 kg/m2) and the percentage of cases with abnormal alanine aminotransferase level in haloperidol group were lower than that in olanzapine group at the 6 weeks(16.98% vs.28.07%);the changes of triglyeride in haplopeidol were lower than that in olanzapine group at the 4 weeks with P 0.05(0.24 ± 0.12 mmol/L vs.0.57 ± 0.07 mmol/L).The incidence rate of extrapyramidal symptoms were higher in haloperidol group than in olanzapine group(73.3% vs 10.71%,P 0.05).Conclusion These results demonstrate that haploperidol is as effective as olanzapine in treatment for schizophrenia.Olanzapine can significantly increase body weight and adverse metablic effects whereas haloperidol can cause higher incidence of extrapyramidal syndrome(EPS).The double-blind,fixed low dose studies on haloperidol with a larger sample size are needed to confirm the results of our study.